The cellular level and activity of the general amino acid permease, the product of the GAP1 gene of Saccharomyces cerevisiae, are regulated at the level of transcription by two systems, the products of URE2/GLN3 and NIL1 in response to the nitrogen sources of the growth medium and inactivation in response to the presence of glutamine or glutamate. Active permease is phosphorylated. The addition of glutamine causes rapid dephosphorylation and inactivation of the permease with the same kinetics, which is followed by slower disappearance of the protein. These results suggest that inactivation of the permease results from its dephosphorylation.
The minimal medium which supports the most rapid growth of the yeast Saccharomyces cerevisiae is one in which glutamine, asparagine, or ammonia serves as the sole source of nitrogen. The presence of one of these compounds results in the repression of enzymes and permeases required for the utilization of other nitrogen sources that support growth at slower rates. An important element in this nitrogen regulation is control of the synthesis of the general amino acid permease, the product of the GAP1 gene (21) , which results in high levels of Gap1p activity during the initial stages of nitrogen starvation and during growth on a poor source of nitrogen and low levels of Gap1p activity during growth on glutamine or glutamate (8) . Control of Gap1p activity appears to be very complex, involving multiple transcriptional and posttranscriptional systems which act in response to the nitrogen source. One reason that Gap1p activity is so tightly regulated is that the lack of Gap1p activity caused by growth on good nitrogen sources in turn results in secondary regulatory effects due to inducer exclusion, thus preventing induction of the catabolic enzymes needed to utilize poor nitrogen sources (26) .
The general amino acid permease can transport all of the naturally occurring L-amino acids found in proteins and related compounds, such as ornithine and citrulline, and several Damino acids and toxic amino acid analogs (44) . Grenson and colleagues first observed Gap1p activity in yeast strains that lacked certain specific high-affinity amino acid permeases, such as specific arginine, lysine, or methionine permeases, and were resistant to the toxic effects of corresponding amino acid analogs when the nitrogen source was ammonia (16) . These strains regained sensitivity to analogs through 10-to 100-fold increases in the rates of uptake of corresponding amino acids when the poor nitrogen source proline was used in place of ammonia, a condition which was exploited to select the first gap1 mutants. GAP1 has previously been cloned and sequenced; the deduced peptide sequence is homologous to that of other fungal amino acid permeases (21) .
Gap1p permease is inactivated by the addition of a rich nitrogen source such as glutamine, glutamate, or ammonia to cells growing on a poor nitrogen source. A per1 strain which lacked the ammonia inactivation response also had 60-foldhigher levels of Gap1p activity during growth on ammonia than those of the wild-type strain (8) , suggesting that posttranscriptional controls can, in effect, negate transcriptional control.
Grenson and Hou have described several mutations, none of which appears to be per1, that affect ammonia-mediated permease inactivation (13) (14) (15) . Their results suggested that the product of NPR1 was required for Gap1p activity, even in the absence of ammonia, unless the ammonia inactivation system was defective, as in a npi1 or npi2 mutant. NPR1 has previously been cloned, and its deduced amino acid sequence was shown to be homologous to those of protein kinases (42) . It is not known whether the product of NPR1 produces its effect directly by interacting with Gap1p or indirectly by counteracting the function of Npi1p and Npi2p.
There appears to be coordinate expression of a number of nitrogen-regulated genes which requires the product of GLN3, a transcriptional activator which contains a zinc finger that is homologous to those in GATA factors (33, 41) and to the fungal nitrogen regulators encoded by areA (23) and nit-2 (11, 12) . Normal nitrogen regulation requires the product of URE2 to prevent transcriptional activation by Gln3p during growth on a repressing nitrogen source like glutamine. Both GLN1 and GDH2 are transcriptionally activated by the Ure2p/Gln3p system so that their expression is lowest during growth on glutamine and highest during growth on glutamate (6, 30, 31) . Gap1p activity in glutamate-grown cells has been shown to be higher than that in glutamine-grown cells; this difference in activity did not exist in gln3 cells, although the highest Gap1p activities occurred during growth on poor nitrogen sources such as proline in both GLN3 and gln3 strains (7).
Here we present evidence that Gln3p activates the transcription of GAP1 during growth on glutamate, that Ure2p prevents the activation of GAP1 transcription by Gln3p during growth on glutamine, and that an activator other than Gln3p is responsible for the activation of GAP1 transcription during growth on ammonia or urea and in the absence of any source of nitrogen. We used epitope-tagged Gap1p to show that active Gap1p is phosphorylated and that its inactivation by triggered glutamine coincides with its dephosphorylation.
MATERIALS AND METHODS
Strains and media. The S. cerevisiae strains used in this work are listed in Table 1 . Minimal yeast medium was composed of Difco yeast nitrogen base without amino acids and ammonium sulfate (Difco Laboratories, Detroit, Mich.) with 2% glucose as the carbon source and with the nitrogen source added to 0.1% (amino acids) or 0.2% (ammonium sulfate). Nutritional supplements were added at the concentrations specified by Sherman et al. (37) . Yeast genetic techniques were performed according to the methods of Sherman et al. (37) , and DNA transformation of S. cerevisiae was accomplished by the lithium acetate protocol (20) .
DNA manipulations and preparations. DNA manipulations were performed as described by Maniatis et al. (27) , and enzymes were used according to the recommendations of the supplier (New England Biolabs, Beverly, Mass.). Bacterial plasmids were prepared by the alkaline lysis method for minipreparations and large-scale preparations (1) . CsCl ethidium bromide centrifugation of largescale preparations was performed as described by Maniatis et al. (27) . Plasmids were recovered from S. cerevisiae strains by a teeny prep method (39) .
Selections for resistance to canavanine. Selection for can1 mutants was performed by growing a yeast extract-peptone-dextrose culture of strain JT113 to saturation, washing it twice with sterile water, and plating ca. 10 7 cells per minimal glucose-ammonia-uracil-50 M L-canavanine plate. Selection for gap1 mutants was performed with strain MS1 by following the protocol described above and plating on minimal glucose-proline-uracil-50 M L-canavanine plates.
Permease assays. Permease assays were performed as described by Courchesne and Magasanik (8) . Twenty-five-milliliter cultures were grown to 80 to 100 Klett units (green filter). Cells from a 5-ml aliquot were harvested by filtration through a 0.8-m-pore-size, mixed cellulose ester filter (Millipore, Bedford, Mass.) and washed with distilled water, and cells were resuspended in 5 ml of prewarmed (30ЊC), aerated minimal medium with 2% glucose and no nitrogen source or other supplements. A 1-ml sample was filtered through a cellulose filter, washed with distilled water, and resuspended in 1 ml of water for a determination of protein content by the Lowry assay (9) . Forty microliters of 100ϫ 14 C-amino acid was added; the culture was vortexed; and five samples (0.5 ml each) were taken at 20-s intervals, filtered through no. 30 glass fiber filters (Schleicher and Schuell, Keene, N.H.) in a filter manifold, and immediately rinsed with 0.1% unlabelled amino acid. Filters were dried under a heat lamp and counted in 5 ml of Scintiverse (Fisher Scientific, Fair Lawn, N.J.). Units of specific activity were calculated as nanomoles of amino acid accumulated per minute per milligram of protein. The specific activity of each amino acid used in uptake assays was 0.5 mCi/mmol, and the final concentrations employed in assays were 0.2 mM for Lowry protein assays. Fifty-microliter samples of yeast cells were prepared for assays by adding 50 l of water and 100 l of 1 M NaOH and heating to 95ЊC for 10 min. After being cooled to room temperature, 1 ml of Lowry reagent (2 ml of 0.5% CuSO 4 -5 H 2 O, 2 ml of 2% Na tartrate, 96 ml of 2% Na 2 CO 3 ) was added, mixed, and incubated for 10 min. Then 100 l of Folin reagent (Sigma, St. Louis, Mo.) diluted 1:1 with water was added during vortexing. After 40 min, the optical density at 670 nm (OD 670 ) was read. The protein standard was bovine serum albumin fraction V (Boehringer Mannheim, Indianapolis, Ind.). All assays were done in triplicate.
Glutamine synthetase assays. Total glutamine synthetase activity was measured by a transferase assay as previously described (32) .
Construction of a GAP1-lacZ translational fusion. A 1.8-kb DraI fragment which contains the entire upstream region and the first 165 bases of the open reading frame of GAP1 was subcloned into the DraI-SspI sites of the Amp r gene of pBR322. One of the plasmids which recreated the DraI site in the open reading frame was designated pMS24. It was cut with DraI and BamHI 12-mer linkers (New England Biolabs) and ligated to the blunt ends, and then it was digested with BamHI and religated; one of the resulting plasmids was chosen to be pMS25. A 1.7-kb Asp718-BamHI fragment was liberated from pMS25 and cloned into the Asp718-BamHI backbone of pSLF⌬178K (10) , which resulted in pMS26, a 2m URA3 GAP1-lacZ fusion plasmid. To create an ARS-CEN URA3 version of this plasmid, pMS26 was digested with Asp718, filled in with Klenow fragment, and then digested with BamHI and the 1.7-kb BamHI-Asp718 fragment was subcloned into the SmaI-BamHI backbone of pBL101 (24) .
TN10LUK insertional mutagenesis. TN10LUK insertions were obtained in the Ycp50 shuttle vector clone of GAP1 known as pMS1 by the method of Huisman et al. (19) . Approximately 5,000 kanamycin-resistant colonies were pooled, plasmid DNA was purified from the pool, lambda-resistant Escherichia coli cells were transformed with plasmid DNA, and transformants were selected for ampicillin and kanamycin resistance. The resulting transformants were restriction mapped to determine the site of integration and the orientation of TN10LUK.
Construction of a GAP1 null allele. Plasmid pMS16 was digested with BamHI and EcoRV, and this fragment was replaced with a BglII linker, resulting in plasmid pMS18. Plasmid pMS18 was digested with EcoRI, which removes an 840-bp fragment that includes the first 210 bp of the promoter and roughly one-third of the open reading frame, and the EcoRI fragment was replaced with a BamHI linker, resulting in plasmid pMS19. Disruption plasmid pMS20 was constructed by digesting pMS19 with BamHI and inserting a 3.0-kb BglII fragment with the LEU2 gene from Yep13. A gap1::LEU2 disruption strain was created by transforming a 4.5-kb BglII fragment from pMS20 into strain MS138, selecting for LEU2, and testing for Gap1p activity. A gap1 LEU2 clone was designated MS143.
␤-Galactosidase assays. Fresh transformants were patched to minimal ammonia plates supplemented with 0.1% Casamino Acids (Difco Laboratories) and adenine for 1 or 2 days of growth, and these patches were used to inoculate 5-ml minimal cultures with various nitrogen sources for overnight growth. One milliliter of culture was harvested by centrifugation at an OD 600 of 0.8 to 1.1, washed once with assay buffer, and assayed by the method of Miller (28) . Units were calculated as described by Miller (28) and normalized to OD 600 . At least two independent transformants were assayed for each determination.
Preparation of RNA and Northern (RNA) analysis. Cultures were grown in minimal glucose medium to 80 to 100 Klett units (green filter). All cultures were supplemented with adenine, histidine, and uracil. Gap1p permease assays were performed on the same cultures. Total yeast RNA was isolated by the method described by Carlson and Botstein (3) , and the yield was determined by A 260 . Ten micrograms of total RNA per lane of a formaldehyde agarose gel was loaded and blotted, and Northern hybridization analysis was carried out as previously described (4). Probes for hybridization were produced by nick translation according to the directions of the supplier (Boehringer Mannheim). The GAP1 probe used was a 1.8-kb BglII-XhoI fragment, and the TUB1 probe was a 0.9-kb SalI-Asp718 fragment.
Western (immunoblot) hybridizations and immunoprecipitations. The antibody used was the mouse monoclonal antibody 12CA5 raised against the HA1 epitope of the influenza virus hemagglutinin protein and was purchased from Babco (Berkeley, Calif.). Crude protein extracts were prepared from 3 ml of yeast culture at an OD 600 of 1.0 by the alkaline lysis (100 l of 1.85 M NaOH-7% ␤-mercaptoethanol for 10 min on ice) method of Silve et al. (38) . The crude lysate was trichloroacetic acid precipitated (100 l of 50% trichloroacetic acid for 10 min on ice), rinsed with 0.5 ml of 1 M Tris base, and resuspended in 100 l of 2ϫ sample buffer (4% sodium dodecyl sulfate [SDS], 0.1 M Tris-HCl [pH 6.8], 4 mM EDTA, 20% glycerol, 2% ␤-mercaptoethanol, 0.02% bromophenol blue) (38) . Ten microliters of protein extract in sample buffer per lane of a 7.5% acrylamide gel was loaded, blotted to a polyvinylidene difluoride membrane (Immobilon-P; Millipore), and hybridized as previously described by Haldi and Guarente (17) . The secondary antibody employed was an affinity-purified alkaline phosphatase-conjugated rabbit anti-mouse immunoglobulin G antibody from Cappel Laboratories (Durham, N.C.). Blots were developed with the chromogenic substrates 5-bromo-4-chloro-3-indolylphosphate toluidinium and nitroblue tetrazolium according to the directions of the supplier (Bio-Rad, Richmond, Calif.) or with 125 I-labelled protein A (NEN, Boston, Mass.) as outlined by Harlow and Lane (18) .
Pulse labelling with [
35 S]methionine was performed by the method of Silve et al. (38) . Cells were grown in low-sulfate minimal medium (22) to an OD 600 of 1.0, and then 10 ml of culture was centrifuged and resuspended in fresh medium to an OD 600 of 10. [
35 S]methionine was added to 200 Ci per ml, labelling was allowed to proceed for 3 min at 30ЊC, and then cells were pelleted by centrifugation and broken by alkaline lysis.
In vivo labelling with 32 P i was done in low-phosphate minimal medium according to the protocol of Kolodziej and Young (22) on cells grown in 100 M phosphate minimal medium. Cultures were grown to an OD 600 of 0.5, 32 P i was added to 400 Ci/ml, cultures were incubated for another 6 h to reach an approximate OD 600 of 1.0, and then a 3-ml sample was processed by alkaline lysis.
Immunoprecipitations were performed as described by Silve et al. (38) . After alkaline lysis, trichloroacetic acid precipitation, and a rinse with Tris base, the pellet was resuspended in 100 l of SDS sample buffer and heated for 10 min at 37ЊC. The resuspension was diluted to 1 ml in immunoprecipitation buffer (50 mM Tris-HCl [pH 7.4], 150 mM NaCl, 5 mM EDTA, 1% Triton X-100, and protease inhibitors leupeptin [1 g/ml], pepstatin [5 g/ml], and aprotinin [5 g/ml]) and was centrifuged for 20 min at 12,000 ϫ g at 4ЊC. Phosphorylation samples were resuspended in immunoprecipitation buffer (150 mM NaCl, 5 mM EDTA, 1% Triton X-100, 1 g of leupeptin per ml, 5 g of pepstatin per ml, 5 g of aprotinin per ml, and phosphatase inhibitors sodium phosphate [50 mM] [pH 7.2], NaF [1 mM], and Na 3 VO 4 [0.4 mM]). The supernatant was diluted to 3 ml with immunoprecipitation buffer, samples were counted, the counts per minute per sample were normalized before proceeding with immunoprecipitation, 15 l of anti-hemagglutinin antibody 12CA5 was added, and the mixture was incubated overnight at 4ЊC. The immune complexes were adsorbed to 100 l of protein A-Sepharose beads (Sigma) for 1 h at 4ЊC, the beads were centrifuged and washed with immunoprecipitation buffer three times, and proteins were eluted from the beads by the addition of 60 l of sample buffer. Ten microliters of sample per lane of a 7.5% acrylamide gel was loaded; after electrophoresis, the gel was fixed and dried; the Gap1::Flu1p bands were visualized and counted on a phosphor screen by using version 3.1 of the ImageQuant program (Molecular Dynamics, Sunnyvale, Calif.).
RESULTS
Cloning of the GAP1 gene. The strategy used to clone the GAP1 gene was to select a yeast strain which grew very poorly on a low concentration of an amino acid as the sole nitrogen source, to transform this strain with a yeast genomic library, and then to screen for transformants which grew faster on a low concentration of the same amino acid. Since most amino acids are transported in S. cerevisiae by a high-affinity, lowcapacity specific permease and the low-affinity, high-capacity general amino acid permease, it was necessary to create a mutant strain which lacked both uptake systems (5) . A double mutant was isolated in two steps by selection for resistance to L-canavanine, a toxic arginine analog which is transported into the cell by the arginine permease Can1p and by the general amino acid permease Gap1p (16) . Spontaneous can1 mutants in strain JT113 were selected by plating on minimal ammoniacanavanine medium, and then can1 gap1 mutants were isolated in a second round of selection for canavanine resistance on minimal proline-canavanine medium. Strain MS3 (can1 gap1) had very low levels of Gap1p activity ( 14 C-citrulline uptake) and normal levels of the proline-specific permease Put4p ( 14 Cproline uptake) during growth on proline compared with those of JT113, which suggested that the mutant strain did not have a pleiotropic defect that prevented all amino acid permease activity (Table 2 ). MS3 did not complement a known gap1 mutant, BC14, for Gap1p activity ( Table 2) .
The ura3 can1 gap1 strain MS3 was transformed with either a low-copy-number or a high-copy-number URA3 genomic plasmid library. Five clones were found by simultaneously selecting for URA3 and screening for large, faster-growing colonies on 0.01% arginine. These clones were tested for sensitivity to canavanine and the ability to transport labelled arginine or citrulline during growth on proline. All five clones had regained sensitivity to canavanine during growth on minimal proline plates. Two clones restored only arginine uptake; they were not studied further because they were considered likely to be CAN1 clones. The three remaining clones restored the uptake of both arginine and citrulline and had overlapping restriction digest patterns. Two were from a centromere library, and the other one was from a 2m-based library. The phenotypes of canavanine sensitivity and arginine and/or citrulline transport were lost when strains were cured of the plasmid. The SalI-BamHI region of the putative GAP1 clone was subcloned in the vector Yip5 to create pMS5. Strain MS3 was transformed with BglII-cut pMS5 to integrate the clone into its corresponding chromosomal locus. This strain was crossed to MS138 (can1 GAP1) and sporulated. Thirty tetrads were dissected; none gave rise to a canavanine-resistant gap1 spore which could grow on proline-canavanine plates. Spores from six of these tetrads were also assayed for Gap1p activity and found to be GAP1. Therefore, the clones were GAP1 and not suppressors of gap1.
The restriction map of the GAP1 region is shown in Fig. 1 . The open reading frame of GAP1 was identified by subcloning and insertional mutagenesis with the TN10LUK system (Fig.  1) . The gene was partially sequenced; all sequences matched the GAP1 sequence published by Jauniaux and Grenson (21) .
GAP1 is transcriptionally controlled by two systems. Physiological studies of Gap1p activity had shown that during C-citrulline transported per minute per milligram of total protein as described in Materials and Methods. Put4p permease units of activity were computed as nanomoles of growth on glutamate, there was a small amount of Gap1p activity in a wild-type strain and virtually no activity in a gln3 strain, whereas Gap1p activity was very high in either strain grown on proline (8) . In the wild-type strain, about 25-fold more Gap1p activity was present in proline-grown cells than in glutamate-grown cells. This suggested that independent systems were responsible for the production of Gap1p activity, in which one system (Ure2p/Gln3p) was active during growth on glutamate and a second system was active during growth on proline (7). Similar results were obtained when urea, rather than proline, served as the source of nitrogen.
Transcription of the GAP1 gene was measured by assaying ␤-galactosidase activities in various strains that carried plasmid pMS29, an ars-cen URA3 vector with the GAP1 promoter and the first 53 amino acids of GAP1 fused in frame to lacZ. In wild-type JT113, ␤-galactosidase activity was high during growth on glutamate or urea as the nitrogen source (Table 3) . Growth on glutamine produced little ␤-galactosidase activity.
The gln3 mutant P40-2c/pMS29 produced about 15-to 20-fold-less ␤-galactosidase activity than did the wild-type strain during growth on glutamate and about 2-fold less during growth on urea (Table 3 ). It appears that Gln3p is the primary transcriptional activator of GAP1 during growth on glutamate and that Gln3p contributes to the activation of GAP1 transcription during growth on urea in a wild-type strain, while an independent activator is responsible for about one-half of GAP1 transcription in a wild-type strain grown on urea and for all GAP1 transcription in a gln3 strain grown on urea. We have named this independent activator Nil1p and have evidence that the product of the NIL1 gene has a domain which is homologous to the DNA binding domains of GATA factors, including that of Gln3p (38a).
It has been established that Ure2p is a negative regulator of Gln3p (6, 9) . Genes whose transcription is activated by Gln3p, such as GLN1 and GDH2, are transcribed at high rates during growth on all nitrogen sources in ure2 GLN3 strains. Very high ␤-galactosidase activities were produced on all nitrogen sources in the ure2 deletion strain P40-3c with the GAP1-lacZ translational fusion plasmid pMS29 (Table 3 ). This confirms the role of Ure2p/Gln3p in GAP1 transcription. Northern blots of GAP1 mRNA confirmed the results obtained with the GAP1-lacZ fusion (Fig. 2) . There was strong expression of GAP1 during growth on glutamate in the wildtype strain but only weak expression in the gln3 strain. Expression was high in all strains grown on urea and was also high on all nitrogen sources in a ure2 strain. There was poor expression in both glutamine-grown and glutamate-plus-ammonia-grown wild-type cells, which was expected since growth on glutamate plus ammonia is equivalent to growth on glutamine in wildtype strains (29) . In contrast, this wild-type strain produced large amounts of GAP1 transcript during growth on ammonia or glutamate alone. It is apparent that the mechanism which controls the transcriptional activation of nitrogen-regulated genes like GAP1 does so by monitoring the intracellular concentration of a nitrogen metabolite such as glutamine. Transcription of the GAP1 gene is tightly regulated in response to the nitrogen source by two independent systems, Ure2p/Gln3p and Nil1p. The nitrogen conditions which trigger maximal activation by these systems are different: growth on glutamate results in the activation of GAP1 transcription by Gln3p, on January 7, 2018 by guest http://jb.asm.org/ whereas growth on urea, proline, or ammonia results in the activation of GAP1 transcription by Nil1p. However, while a high level of GAP1 transcription is required for a high level of Gap1p activity, there are posttranscriptional controls which can limit Gap1p activity even when GAP1 is highly transcribed. The prevailing control of permease activity is posttranscriptional. Gap1p permease assays were performed in parallel with mRNA isolation from cultures grown on various nitrogen sources (Fig. 2) . A high level of message resulted in a high level of permease activity only when the nitrogen source was urea or ammonia. This was especially apparent in glutamate-grown GLN3 cells or in ure2 cells grown on glutamine or glutamate. In each of these cases, there were very high levels of mRNA but quite low permease activities. The degree of posttranscriptional regulation of permease activity in glutamate-grown cultures was about 50-fold compared with that of urea-grown cultures of the same strain.
The same results were obtained when ␤-galactosidase assays and permease assays were performed in parallel (Table 3) . Glutamate-grown wild-type cells had 70-fold-less Gap1p activity than urea-grown cells, whereas both cultures produced comparable amounts of ␤-galactosidase activity. The ure2 strain had high levels of ␤-galactosidase activity on all nitrogen sources, yet the Gap1p activity was low when the nitrogen source was glutamine or glutamate.
Thus, growth on glutamate as the nitrogen source results in regulation of the general amino acid permease characterized by a high rate of GAP1 transcription and low Gap1p activity. This allows the cell to exclude the high-capacity uptake of poor nitrogen sources and to quickly adapt to deteriorating nitrogen conditions by a rapid increase in Gap1p activity.
In wild-type cells of the Belgian strain background (⌺1278b), Gap1p function was rapidly inactivated when glutamine, glutamate, or ammonia was added to the medium (8) . A mutant which retained the glutamine or glutamate inactivation response but lacked the ammonia inactivation response as a result of a mutation in the PER1 gene was identified in that study. The per1 strain produced a large amount of Gap1p activity during steady-state growth on ammonia, whereas the wild type produced very little. It is likely that the wild-type strain employed in this work, JT113, is also per1 because it produces a high level of Gap1p activity during growth on ammonia (Fig. 2) . This is a common phenotype for strains related to X2180-1A, the wild-type strain of the Yeast Genetic Stock Center (34) .
It seemed likely that inactivation was solely responsible for the posttranscriptional regulation of the general amino acid permease, but in the absence of a strain that completely lacked the inactivation response, there was no direct way to test this hypothesis. In order to ascertain whether there were additional levels of posttranscriptional control, the relative rates of Gap1p synthesis and the levels of Gap1p protein were determined during growth on various nitrogen sources with the GAP1::FLU1 construct, which encodes an epitope-tagged product (generously provided by Per Ljungdahl).
Epitope-tagged Gap1::Flu1p is functional. An oligonucleotide encoding a 9-amino-acid epitope of the influenza virus hemagglutinin protein HA1 was inserted in the GAP1 sequence corresponding to the N-terminal hydrophilic domain between amino acids 62 and 63 (GAP1::FLU1) (25) . This plasmid complemented the gap1::LEU2 disruption strain MS143 for growth on minimal citrulline, washed agar plates. It was possible to see citrulline growth phenotypes for GAP1 strains only on washed agar media. The Gap1p activity produced by N-terminal-tagged GAP1::FLU1 was about 40% of that by untagged GAP1 in the same ars-CEN plasmid vector (Fig. 3) .
It was possible to visualize Gap1::Flu1p in Western blots of crude cell extracts made by quick alkaline lysis with a monoclonal antibody raised to the HA epitope (12CA5). Similarly, Gap1::Flu1p could be immunoprecipitated from crude alkaline extracts with this antibody.
Posttranscriptional control of Gap1p activity is not translational. It was not clear whether inactivation was solely responsible for the disparity between Gap1p activity and GAP1 transcrip- (Fig. 3A) . Somewhat smaller amounts of Gap1::Flu1p were immunoprecipitated from glutamate-grown cells than from urea-grown cells that were pulse-labelled with [ 35 S]methionine. The approximately 2-fold difference in the amount of labelled Gap1::Flu1p in this experiment cannot account for the 14-fold difference in Gap1::Flu1p activity between glutamate-grown cells and ureagrown cells (Fig. 3B) . In repeat trials, glutamate-grown cells produced as much (or more) labelled Gap1::Flu1p as ureagrown cells (data not shown). Therefore, it seems unlikely that Gap1p is regulated at the translational level.
The relative amounts of total Gap1::Flu1p protein in glutamate-and urea-grown cells were assessed to test the hypothesis that Gap1p activity was correlated with the total amount of Gap1p protein. Steady-state levels of Gap1::Flu1p protein were determined by Western blotting and compared with Gap1p activities in the same cultures (Fig. 3B) . There was approximately 2-to 3-fold less Gap1::Flu1p protein in glutamate-grown cells than in urea-grown cells, whereas activity levels were about 14-fold different. This result indicates that both inactive and active forms of Gap1::Flu1p must be present in these cells.
A comparison of the data gathered for glutamate-and ureagrown cells shows that the largest difference between them was the amount of Gap1p activity and that this difference in activity was too large to be accounted for by the small differences in the transcription of GAP1, synthesis of Gap1::Flu1p, or the total amount of Gap1::Flu1p protein. There are two independent layers of control of Gap1p, transcriptional regulation and posttranslational regulation of activity. Posttranslational regulation of Gap1p activity can obviate a high degree of transcriptional activation of GAP1 during growth on nitrogen sources which trigger permease inactivation, such as glutamate. The fact that most Gap1::Flu1p protein in glutamate-grown cells was inactive ruled out degradation as the immediate mechanism of inactivation, although it is possible that a faster rate of degradation is a consequence of inactivation. It did suggest that active Gap1p and inactive Gap1p were different as a result of either covalent modification or association with another factor. The presence of a secondary band just above the Gap1::Flu1p band in immunoprecipitates of lysates from labelled cells which carried Gap1::Flu1p and its absence in lysates from cells without this plasmid supported the possibility of covalent modification of Gap1p (Fig. 3A) . In addition, multiple bands were seen just above Gap1::Flu1p in a Western blot of lysates from urea-grown cells that expressed GAP1::FLU1, but these bands were not seen in lysates from cells grown on glutamine or glutamate or in cells without the GAP1::FLU1 plasmid (Fig.  3B ). Since these secondary bands represented a small fraction of the total Gap1::Flu1p in urea-grown cells, they may be visualizable by immunoblot only in lysates which have a large amount of Gap1::Flu1p.
Gap1p is phosphorylated. Grenson and colleagues isolated a number of yeast mutants which lacked Gap1p activity but which were GAP1. One of these, npr1, was cloned, and the deduced protein sequence was found to be very homologous to those of protein kinases (42, 43) . Phosphorylation thus seemed to be a candidate for covalent modification of Gap1p which could control Gap1p activity.
The phosphorylation state of Gap1::Flu1p was investigated by immunoprecipitation of lysates from 32 P i -labelled cells. MS143/pPL257 (GAP1::FLU1) was labelled by the addition of 32 P i to low-phosphate minimal medium for 2 to 6 h of growth in mid-log phase. Extracts were prepared by alkaline lysis, Gap1::Flu1p was immunoprecipitated, proteins were resolved by SDS-polyacrylamide gel electrophoresis, and Gap1::Flu1p was quantitated on a phosphor imager. As can be seen in Fig.  4A , the major protein immunoprecipitated from 32 P i -labelled cells was the same size as Gap1::Flu1p immunoprecipitated from [
35 S]methionine-pulse-labelled cells. Glutamate-grown cells had 10-fold-less phosphorylated Gap1::Flu1p than ureagrown cells. In another experiment, there was ninefold-more phosphorylated Gap1::Flu1p in immunoprecipitations of crude lysates from urea-grown cells than from glutamate-grown cells (Fig. 4B) . There was 15-fold-more permease activity in ureagrown cells than in glutamate-grown cells. The addition of glutamine to these phosphorylated cultures for 45 min, which causes a rapid loss of Gap1p activity (8) , also resulted in a drop in the amount of phosphorylated Gap1p in both cultures (Fig.  4B) . There was only a small decrease in the amount of phosphorylated Gap1p in the glutamate-plus-glutamine culture (ca. 2-fold) but over a 12-fold drop in the urea-plus-glutamine culture. This suggested that the phosphorylation state of Gap1p may determine permease activity.
In order to correlate the kinetics of permease inactivation and Gap1p dephosphorylation, we measured the effects of the addition of glutamine to parallel subcultures of MS143/pPL257 grown in urea low-phosphate medium. The result of the experiment showed a strong correlation between the rates of dephosphorylation and inactivation of Gap1::Flu1p (Fig. 5) .
The inactivation of Gap1::Flu1p permease activity and the loss of phosphorylated Gap1::Flu1p could have resulted from a rapid turnover of the protein. This possibility was tested by monitoring both Gap1::Flu1p permease activity and the level of Gap1::Flu1p protein after the addition of glutamine to a urea-grown culture of MS143/pPL257. As before, the loss of permease activity was quite rapid (Fig. 6) . While there was a decrease in the level of Gap1::Flu1p protein, the rate of protein loss was considerably slower than the rate of permease inactivation. In the control subculture, which did not receive glutamine, permease activity and the level of Gap1::Flu1p protein declined slightly over the course of the experiment.
DISCUSSION
Two separate systems regulate the transcription of the GAP1 gene in response to nitrogen growth conditions. This has been demonstrated by assays of ␤-galactosidase activity of GAP1-lacZ fusions and by Northern analysis. The two transcriptional systems, Ure2p/Gln3p and Nil1p, had overlapping but different responses to growth on glutamate, urea, or proline as the nitrogen source but were both inactive during growth on glutamine. The activation of a GAP1-lacZ fusion during growth on glutamate was weaker in a gln3 strain than that in the wild type, as was the synthesis of GAP1 mRNA. It appears that Gln3p is the major activator of GAP1 during growth on glutamate and that Nil1p is the major activator during growth on urea or proline in a gln3 strain. More recent results with a nil1 strain indicate that Gln3p as well as Nil1p activates transcription of GAP1 during growth on urea or proline (unpublished data).
Northern analyses coupled with Gap1p activity assays revealed large differences between the level of transcription and the amount of uptake activity with glutamate as the nitrogen source, whereas when the nitrogen source was urea, proline, or ammonia, the levels of GAP1 mRNA and Gap1p activity were correlated. Since urea-and glutamate-grown cells produced the same amounts of GAP1 mRNA and ␤-galactosidase activity from a GAP1-lacZ translational fusion but there was 15-fold-more Gap1p activity in urea-grown cells than in glutamate-grown cells, the degree of posttranscriptional regulation of Gap1p activity was 15-fold. Experiments with an epitopetagged version of Gap1p indicated that the principal mechanism of posttranscriptional regulation of the general amino acid permease was inactivation of functional permease. Permease inactivation may have secondary effects, such as a faster rate of degradation of inactive permease, which may explain why there was two-to threefold less Gap1p protein in Western blots of lysates from glutamate-grown cultures than from ureagrown cultures. It is clear that the mechanism of inactivation was not the destruction of the permease, since the rate of inactivation was far more rapid than the rate of degradation of the tagged permease.
In order to demonstrate the relationship of dephosphorylation to inactivation, experiments were performed to determine the amounts of Gap1p activity and phosphorylated Gap1p during glutamine inactivation. The kinetics of dephosphorylation and permease inactivation were parallel; therefore, we conclude that there is a strong correlation between the mechanisms of dephosphorylation and inactivation. Permease inactivation and dephosphorylation were very rapid (about 50% of permease activity and phosphorylation was lost in the first 5 min of inactivation), but after the initial drop-off, the rates of inactivation and dephosphorylation slowed considerably. The biphasic shape of these curves could be interpreted as evidence of two processes that result in lower Gap1p activity and phosphorylation. One process is obviously dephosphorylation, which is correlated with the inactivation of the permease, and the slower process is likely to be turnover of the permease, which could be triggered by inactivation.
It could be argued that dephosphorylation is a by-product of the true mechanism of inactivation, which perhaps causes a conformational change of Gap1p, allowing a phosphatase ac- cess to phosphate groups. This would be similar to the case in which Gal4p undergoes a conformational change in the transition from an inactive state to an active state, allowing it to be fortuitously phosphorylated. The phosphorylation status of Gal4p was shown to be unimportant to the ability to become active by mutating the phosphorylation sites (35) . This seems unlikely, however, in view of the homology of the NPR1 product to protein kinases and the role of NPR1 in maintaining Gap1p activity (42) .
There are several overlapping layers of control of the general amino acid permease that are finely tuned to respond to the nitrogen environment of the yeast cell. In general, growth on nitrogen sources that do not result in the fastest doubling times increases the amount of Gap1p activity. Any change in nitrogen conditions that allows faster growth causes an immediate decrease in the amount of Gap1p activity by inactivation of the permease. While it isn't known whether there is a corresponding rapid change in the transcription of GAP1 in response to a shift from limiting nitrogen sources to rich nitrogen sources, there is complex transcriptional control mediated by at least two systems that do not activate GAP1 transcription on the best simple nitrogen source, glutamine. Control of Gap1p activity in turn regulates the synthesis of a host of catabolic enzymes by the mechanism of inducer exclusion (26) . Wellstudied examples of such genes include PUT1 and PUT2, which encode enzymes required for the utilization of proline (2), and CAR1, which encodes arginase (40) . Most of the specific amino acid permeases are high-affinity, low-capacity transporters that are produced constitutively or expressed to a lesser extent in the presence of rich nitrogen sources (5) . They are ideally suited to relieve the cell of some of its amino acid biosynthetic chores and the synthesis of enzymes in these pathways, but they probably do not have sufficient capacity under normal growth conditions to trigger the production of catabolic enzymes.
Thus, the complexity of control of the general amino acid permease is necessary because the import of large quantities of amino acids is a regulatory signal in itself.
